Skip to main content

Ovide Side Effects

Generic name: malathion topical

Medically reviewed by Drugs.com. Last updated on Jun 18, 2024.

Note: This document provides detailed information about Ovide Side Effects associated with malathion topical. Some dosage forms listed on this page may not apply specifically to the brand name Ovide.

Applies to malathion topical: topical lotion.

Serious side effects of Ovide

Along with its needed effects, malathion topical (the active ingredient contained in Ovide) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking malathion topical:

Rare side effects

  • skin rash

Incidence not known

  • blistering and peeling of the skin
  • pain
  • reddened skin
  • swelling

Get emergency help immediately if any of the following symptoms of overdose occur while taking malathion topical:

Symptoms of overdose

Other side effects of Ovide

Some side effects of malathion topical may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common or rare side effects

  • burning, dry, or itching eyes
  • discharge or excessive tearing
  • redness, pain, or swelling of the eye, eyelid, inner lining of the eyelid
  • stinging or irritation of the scalp

Further information

Ovide side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.